WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 6 fonti

The Supreme Court won't take up IRA cases

The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, J&J, Bristol Myers Squibb, Novo Nordisk and Boehringer Ingelheim.

Raccontata daapnews.comedition.cnn.comendpoints.newsstatnews.compbs.orgfiercepharma.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
endpoints.newsStai leggendo1 mesi fa

The Supreme Court won't take up IRA cases

The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases brought by AstraZeneca, J&J, Bristol Myers…

originale

Timeline cronologica

  1. lunedì 18 maggio 2026·apnews.com

    Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations

    The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.

  2. lunedì 18 maggio 2026·edition.cnn.com

    Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare | CNN Politics

    The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the…

fiercepharma.com
1 mesi fa

Supreme Court declines to hear IRA challenges from Novo, AZ and more

Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers continue to fight Medicare price negotiations under the Biden-era Inflation | Following a string…

Leggi questa versione → originale
statnews.com1 mesi fa

Supreme Court rejects challenge to Medicare drug price negotiation

The rejection may make the pharma firms remaining lawsuits more difficult.

Leggi questa versione → originale
apnews.com1 mesi fa

Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations

The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.

Leggi questa versione → originale
edition.cnn.com1 mesi fa

Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare | CNN Politics

The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is expected to save taxpayers and the federal government billions of dollars by…

Leggi questa versione → originale
pbs.org1 mesi fa

Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations with government

The negotiation program was created as part of the 2022 Inflation Reduction Act, which capped years of debate over whether the federal government should be allowed to haggle directly with manufacturers over the prices…

Leggi questa versione → originale
  • lunedì 18 maggio 2026·endpoints.news

    The Supreme Court won't take up IRA cases

    The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare drug price negotiations. The justices declined to review multiple cases…

  • lunedì 18 maggio 2026·statnews.com

    Supreme Court rejects challenge to Medicare drug price negotiation

    The rejection may make the pharma firms remaining lawsuits more difficult.

  • lunedì 18 maggio 2026·pbs.org

    Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations with government

    The negotiation program was created as part of the 2022 Inflation Reduction Act, which capped years of debate over whether the federal government should be allowed to haggle…

  • lunedì 18 maggio 2026·fiercepharma.com

    Supreme Court declines to hear IRA challenges from Novo, AZ and more

    Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers continue to fight Medicare price negotiations under the…